Learn why this royalty company believes it is the best way to play commodities and inflation. on 06/22/2021. Learn More

Streetwise Reports' Article Archives — November 2016 back to current month (2)

Agreement Launches RXi Pharmaceuticals into Dynamic Immuno-Oncology Arena (11/14/2016)

By securing an exclusive option to acquire MirImmune Inc., RXi Pharmaceuticals has expanded its reach into the "high-value" field of immuno-oncology, a move that has energized the company and prompted a pair of analysts to express optimism about RXi's future.

more>

Why the Election Is Not as Relevant to Drug Stocks as You Might Believe (11/02/2016)

Due to drug pricing controversies, there has been much concern about how the outcome of the upcoming election will affect pharmaceutical stocks. Dr. Len Yaffe of Stoc*Doc Partners sheds light on the issues in this analysis of drug price negotiation policy, and focuses in on one California ballot proposition that aims to rein in costs.

more>

More Archives

2021May Apr Mar Feb Jan

2020Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2019Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2018Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2017Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

2016Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe

Notable Quotes

"Momentum continues to build for VIV."
– Joseph Gomes, Wm Smith & Co.